Gralise
Pricing Report NDC 13913-005-19

Latest NADAC: $9.79457 per EA · Effective May 01, 2022 · Est. package price $881.51 (90 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Gralise (NDC 13913-005-19) is $9.79457 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since May 01, 2022.

As a provided by Assertio Therapeutics, Inc., this medication is distributed in a 90 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.79457
Per EA

Effective Date
May 01, 2022
Billable Units
90 EA
Estimated Package Price
$881.51
Data Status
As of Sep 28, 2022
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Oct 2013, the NADAC wholesale price for (NDC ) has moved within a range of $2.97265 to $9.79457 per EA. Over this 8 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$2.9727 - $9.7946
Market Volatility
229.49% Variance
Latest Trend
6.00%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
May 01, 2022 $9.79457 EAC/I - Chain or Independent PharmacyCode 2B - Brand
May 01, 2022 $9.79457 EAC/I - Chain or Independent PharmacyCode 3B - Brand
May 01, 2022 $9.79457 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Apr 20, 2022 $9.24007 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 23, 2021 $9.19569 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 23, 2021 $9.19569 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Apr 12, 2021 $9.17831 EAC/I - Chain or Independent PharmacyCode 3B - Brand
Apr 12, 2021 $9.17831 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Sep 23, 2020 $8.91099 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 23, 2020 $8.91099 EAC/I - Chain or Independent PharmacyCode 2B - Brand
Sep 23, 2020 $8.91099 EAC/I - Chain or Independent PharmacyCode 4B - Brand
Nov 20, 2019 $8.94586 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026